drugset / Trial / NCT00445497

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

NCT00445497

Phase 3 Unknown 400 enrolled Clatterbridge Centre for Oncology
RandomizedSupportive care

Summary

RATIONALE: Finishing an antibiotic regimen at home may be as effective as receiving it in the hospital. It is not yet known whether early hospital discharge is as effective as standard inpatient care in cancer patients receiving antibiotics for febrile neutropenia. PURPOSE: This randomized phase III trial is studying early hospital discharge and comparing it with standard inpatient care in cancer patients receiving antibiotics for febrile neutropenia.

Timeline

Start
2007-07
Primary completion
2010-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Amoxicillin Other / unclassified Oral
Background Ciprofloxacin Small molecule Oral